Signaling by TGF-beta Receptor Complex in Cancer

Stable Identifier
R-HSA-3304351
DOI
10.3180/REACT_169122.1
Type
Pathway
Species
Homo sapiens
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
Signaling by TGF-beta Receptor Complex in Cancer
Click the image above or here to open this pathway in the Pathway Browser
Signaling by the TGF-beta receptor complex is tumor suppressive, as it inhibits cell growth and promotes cell differentiation and apoptosis (Shipley et al. 1986, Hannon et al. 1994, Datto et al. 1995, Chen et al. 2002, Azar et al. 2009). TGF-beta signaling is frequently impaired in cancer, mostly through SMAD4 gene deletion or loss-of-function mutations (described in the pathway Loss of Function of SMAD4 in Cancer), which are especially frequent in pancreatic cancer (Hahn et al. 1996, Shi et al. 1997, Fleming et al. 2013). Signaling by TGF-beta receptor complex can also be disrupted by loss-of-function mutations in SMAD2 and SMAD3 (Fleming et al. 2013), as described in the pathway Loss of Function of SMAD2/SMAD3 in Cancer, or loss-of-function mutations in TGFBR2 (TGF-beta receptor II) (Markowitz et al. 1995, Garrigue-Antar et al. 1995, Parsons et al. 1995, Grady et al. 1999), as described in the pathway Loss of Function of TGFBR2 in Cancer, or TGFBR1 (TGF-beta receptor I) (Chen et al. 1998, Chen et al. 2001, Goudie et al. 2011), as described in the pathway Loss of Function of TGFBR1 in Cancer.

In advanced cancer, signaling by TGF-beta may be tumor promoting, as it induces epithelial-to-mesenchymal transition (EMT), thereby increasing invasiveness (Cui et al. 1996, Guasch et al. 2007, reviewed by Heldin et al. 2012).
Literature References
PubMed ID Title Journal Year
12150994 E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression

Chen, CR, Kang, Y, Siegel, PM, Massague, J

Cell 2002
17936557 Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia

Guasch, G, Schober, M, Pasolli, HA, Conn, EB, Polak, L, Fuchs, E

Cancer Cell 2007
9809982 Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer

Chen, T, Carter, D, Garrigue-Antar, L, Reiss, M

Cancer Res. 1998
19834456 4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation

Azar, R, Alard, A, Susini, C, Bousquet, C, Pyronnet, S

EMBO J. 2009
7777546 Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

Datto, MB, Li, Y, Panus, JF, Howe, DJ, Xiong, Y, Wang, XF

Proc. Natl. Acad. Sci. U.S.A. 1995
11477574 Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases

Chen, T, Yan, W, Wells, RG, Rimm, DL, McNiff, J, Leffell, D, Reiss, M

Int. J. Cancer 2001
21358634 Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1

Goudie, DR, D'Alessandro, M, Merriman, B, Lee, H, Szeverényi, I, Avery, S, O'Connor, BD, Nelson, SF, Coats, SE, Stewart, A, Christie, L, Pichert, G, Friedel, J, Hayes, I, Burrows, N, Whittaker, S, Gerdes, AM, Broesby-Olsen, S, Ferguson-Smith, MA, Verma, C, Lunny, DP, Reversade, B, Lane, EB

Nat. Genet. 2011
7761852 Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

Markowitz, S, Wang, J, Myeroff, L, Parsons, R, Sun, L, Lutterbaugh, J, Fan, RS, Zborowska, E, Kinzler, KW, Vogelstein, B

Science 1995
8752208 TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

Cui, W, Fowlis, DJ, Bryson, S, Duffie, E, Ireland, H, Balmain, A, Akhurst, RJ

Cell 1996
7585632 Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer

Parsons, R, Myeroff, L, Liu, B, Willson, JK, Markowitz, SD, Kinzler, KW, Vogelstein, B

Cancer Res. 1995
9927040 Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers

Grady, WM, Myeroff, L, Swinler, SE, Rajput, A, Thiagalingam, S, Lutterbaugh, JD, Neumann, A, Brattain, MG, Chang, J, Kim, SJ, Kinzler, KW, Vogelstein, B, Willson, JK, Markowitz, S

Cancer Res. 1999
9214508 A structural basis for mutational inactivation of the tumour suppressor Smad4

Shi, Y, Hata, A, Lo, RS, Massagué, J, Pavletich, NP

Nature 1997
7664267 Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells

Garrigue-Antar, L, Muñoz-Antonia, T, Antonia, SJ, Gesmonde, J, Vellucci, VF, Reiss, M

Cancer Res. 1995
11406536 Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas

Chen, T, Triplett, J, Dehner, B, Hurst, B, Colligan, B, Pemberton, J, Graff, JR, Carter, JH

Cancer Res. 2001
8078588 p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

Hannon, GJ, Beach, D

Nature 1994
23139211 SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer

Fleming, NI, Jorissen, RN, Mouradov, D, Christie, M, Sakthianandeswaren, A, Palmieri, M, Day, F, Li, S, Tsui, C, Lipton, L, Desai, J, Jones, IT, McLaughlin, S, Ward, RL, Hawkins, NJ, Ruszkiewicz, AR, Moore, J, Zhu, HJ, Mariadason, JM, Burgess, AW, Busam, D, Zhao, Q, Strausberg, RL, Gibbs, P, Sieber, OM

Cancer Res. 2013
8553070 DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

Hahn, SA, Schutte, M, Hoque, AT, Moskaluk, CA, da Costa, LT, Rozenblum, E, Weinstein, CL, Fischer, A, Yeo, CJ, Hruban, RH, Kern, SE

Science 1996
2418960 Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium

Shipley, GD, Pittelkow, MR, Wille, JJ, Scott, RE, Moses, HL

Cancer Res. 1986
22710176 Regulation of EMT by TGF? in cancer

Heldin, CH, Vanlandewijck, M, Moustakas, A

FEBS Lett. 2012
Participants
Events
Participates
as an event of
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Cross References
Mondo
Authored
Meyer, S  (2013-08-08)
Akhurst, RJ  (2013-08-08)
Orlic-Milacic, M  (2013-08-08)
Reviewed
Meyer, S  (2013-08-08)
Akhurst, RJ  (2013-08-08)
Created
Orlic-Milacic, M  (2013-04-23)
Cite Us!